$IBIO This article (Oct 13th 2020) from The Lancet describes " two phase 3 efficacy studies of a recombinant quadrivalent virus-like particle (QVLP) influenza vaccine manufactured in plants". Seasonal Flu related but still relevant as far as "plant derived human vaccine". thelancet.com/journals/lanc...
  • 1
1 Like